JP2000506367A - ▲ii▼型コラーゲンの調製法 - Google Patents
▲ii▼型コラーゲンの調製法Info
- Publication number
- JP2000506367A JP2000506367A JP9515334A JP51533497A JP2000506367A JP 2000506367 A JP2000506367 A JP 2000506367A JP 9515334 A JP9515334 A JP 9515334A JP 51533497 A JP51533497 A JP 51533497A JP 2000506367 A JP2000506367 A JP 2000506367A
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- tissue
- type
- protease
- cartilage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000000503 Collagen Type II Human genes 0.000 title claims description 66
- 108010041390 Collagen Type II Proteins 0.000 title claims description 66
- 238000002360 preparation method Methods 0.000 title description 9
- 238000000034 method Methods 0.000 claims abstract description 62
- 210000000845 cartilage Anatomy 0.000 claims abstract description 39
- 108091005804 Peptidases Proteins 0.000 claims abstract description 25
- 239000004365 Protease Substances 0.000 claims abstract description 25
- 239000003929 acidic solution Substances 0.000 claims abstract description 13
- 230000002378 acidificating effect Effects 0.000 claims abstract description 11
- 238000013019 agitation Methods 0.000 claims abstract description 6
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims abstract description 5
- 210000001519 tissue Anatomy 0.000 claims description 67
- 102000016611 Proteoglycans Human genes 0.000 claims description 46
- 108010067787 Proteoglycans Proteins 0.000 claims description 46
- 210000001562 sternum Anatomy 0.000 claims description 39
- 102000012422 Collagen Type I Human genes 0.000 claims description 30
- 108010022452 Collagen Type I Proteins 0.000 claims description 30
- 229920001436 collagen Polymers 0.000 claims description 27
- 102000008186 Collagen Human genes 0.000 claims description 26
- 108010035532 Collagen Proteins 0.000 claims description 26
- 102000035195 Peptidases Human genes 0.000 claims description 24
- 108090000284 Pepsin A Proteins 0.000 claims description 23
- 102000057297 Pepsin A Human genes 0.000 claims description 23
- 229940111202 pepsin Drugs 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 23
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 108090000631 Trypsin Proteins 0.000 claims description 19
- 102000004142 Trypsin Human genes 0.000 claims description 19
- 229940088598 enzyme Drugs 0.000 claims description 19
- 239000012588 trypsin Substances 0.000 claims description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- 241000287828 Gallus gallus Species 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 13
- 235000019419 proteases Nutrition 0.000 claims description 13
- 235000019833 protease Nutrition 0.000 claims description 6
- 108090000526 Papain Proteins 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 235000019834 papain Nutrition 0.000 claims description 5
- 229940055729 papain Drugs 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 108090001069 Chymopapain Proteins 0.000 claims description 4
- 108090000270 Ficain Proteins 0.000 claims description 4
- 102000035092 Neutral proteases Human genes 0.000 claims description 4
- 108091005507 Neutral proteases Proteins 0.000 claims description 4
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 claims description 4
- 229960002976 chymopapain Drugs 0.000 claims description 4
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 claims description 4
- 235000019836 ficin Nutrition 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 108090000317 Chymotrypsin Proteins 0.000 claims description 2
- 229960002376 chymotrypsin Drugs 0.000 claims description 2
- 108090000145 Bacillolysin Proteins 0.000 claims 3
- 101800000263 Acidic protein Proteins 0.000 claims 1
- 108010019160 Pancreatin Proteins 0.000 claims 1
- 229940055695 pancreatin Drugs 0.000 claims 1
- 230000017854 proteolysis Effects 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 239000010457 zeolite Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 25
- 150000003839 salts Chemical class 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- 239000000872 buffer Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- 235000013372 meat Nutrition 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 108090000783 Renin Proteins 0.000 description 6
- 102100028255 Renin Human genes 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 210000002808 connective tissue Anatomy 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IAJILQKETJEXLJ-KLVWXMOXSA-N (2s,3r,4r,5r)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid Chemical compound O=C[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-KLVWXMOXSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 102000005600 Cathepsins Human genes 0.000 description 4
- 108010084457 Cathepsins Proteins 0.000 description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- 210000001188 articular cartilage Anatomy 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- -1 halide salt Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 206010034203 Pectus Carinatum Diseases 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229960000789 guanidine hydrochloride Drugs 0.000 description 3
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 102000003902 Cathepsin C Human genes 0.000 description 2
- 108090000267 Cathepsin C Proteins 0.000 description 2
- 102000004266 Collagen Type IV Human genes 0.000 description 2
- 108010042086 Collagen Type IV Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 108010070926 Tripeptide aminopeptidase Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 108010057788 chymotrypsin B Proteins 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 229910003002 lithium salt Inorganic materials 0.000 description 2
- 159000000002 lithium salts Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 102000003908 Cathepsin D Human genes 0.000 description 1
- 108090000258 Cathepsin D Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 1
- 241001433070 Xiphoides Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 150000008045 alkali metal halides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 239000008203 oral pharmaceutical composition Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.非加工脊椎動物軟骨組織から軟骨膜の除去を容易にする方法で、上記軟骨か ら上記軟骨膜を切断または緩めるのに十分な時間の攪拌の下で、酸性プロテアー ゼを含む酸性溶液と上記軟骨を接触させることを含む方法。 2.上記軟骨のソースがチキン胸骨である請求項1記載の方法。 3.上記酸性プロテアーゼがペプシンである請求項2記載の方法。 4.上記ペプシンの濃度が上記酸性溶液のリットル当たり約100から約500mgで ある請求項3記載の方法。 5.上記酸性溶液の酸性化する試薬が0.5M酢酸である請求項4記載の方法。 6.上記処理が約12から約72時間継続する請求項5記載の方法。 7.上記処理が約24から約48時間継続する請求項5記載の方法。 8.上記処理が約4℃から約37℃の温度で実施される請求項6記載の方法。 9.上記処理が約20℃の温度で実施される請求項6記載の方法。 10.I型コラーゲンから実質的にフリーなII型コラーゲン含有組織からプロテオ グリカンを除去する方法で、上記組織を中性プロテアーゼ含有溶液と接触させ、 上記中性プロテアーゼは組織に対するプロテアーゼの重量比が0.05%から5%の範 囲内で存在し、上記溶液は溶液内の上記組織から上記プロテオグリカンを抽出す るのに本質的に十分な時間で攪拌され、上記パウダー化組織を回収することを含 む方法。 11.上記組織が微粉化の前に軟骨膜が除去されている微粉化軟骨である請求項10 記載の方法。 12.上記軟骨の上記ソースがチキン胸骨である請求項10記載の方法。 13.上記プロテアーゼがキモトリプシン、パンクレアチン、パパイン、フィシン 、キモパパイン、膵ペプチダーゼ、及びトリプシンより成る群から選択され、上 記プロテアーゼが組織に対するプロテアーゼの重量比が約0.05から約5%で存在す る請求項11記載の方法。 14.上記プロテアーゼがトリプシンであり、上記トリプシンが組織に対するプロ テアーゼの重量比が約0.05から約5%で存在する請求項12記載の方法。 15.上記トリプシンが約0.8%の濃度で存在する請求項10記載の方法。 16.上記時間が約8から約36時間である請求項12記載の方法。 17.上記時間が約15から20時間である請求項13記載の方法。 18.上記接触が約4℃から約35℃の温度で実施される請求項10記載の方法。 19.上記接触が約4℃の温度で実施される請求項15記載の方法。 20.II型コラーゲン、プロテオグリカン及びI型コラーゲン含有軟骨膜を含む脊 椎動物由来の肉及び骨のないコラーゲン組織からI型コラーゲン及び他の不純物 の実質的にフリーなII型コラーゲンを含む産物を得るための方法で、該方法は: 上記膜を切断または緩めるのに十分な時間、酸性プロテアーゼを含む酸性溶液 と上記組織を攪拌と共に接触させ、I型コラーゲンの実質的にフリーな上記組織 を回収し;及びその後 大体中性のpHの溶液と上記組織を攪拌と共に接触させ、上記溶液はプロテアー ゼが上記組織に含まれるプロテオグリカンを分離するのに十分な時間、プロテア ーゼ:組織の重量比が0.05%-5%の範囲内での中性プロテアーゼを含み、I型コラ ーゲンとプロテオグリカンの両者が実質的にフリーな上記組織を回収する方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US972396P | 1996-01-05 | 1996-01-05 | |
| US60/009,723 | 1996-01-05 | ||
| PCT/US1997/000806 WO1997025435A1 (en) | 1996-01-05 | 1997-01-03 | Method for preparation of type ii collagen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000506367A true JP2000506367A (ja) | 2000-05-30 |
| JP3935938B2 JP3935938B2 (ja) | 2007-06-27 |
Family
ID=21739352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51533497A Expired - Fee Related JP3935938B2 (ja) | 1996-01-05 | 1997-01-03 | ▲ii▼型コラーゲンの調製法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5840848A (ja) |
| EP (1) | EP0871763B1 (ja) |
| JP (1) | JP3935938B2 (ja) |
| KR (1) | KR19990071782A (ja) |
| AT (1) | ATE423568T1 (ja) |
| AU (1) | AU705719B2 (ja) |
| BR (1) | BR9706922A (ja) |
| CA (1) | CA2238439C (ja) |
| DE (1) | DE69739275D1 (ja) |
| ES (1) | ES2320939T3 (ja) |
| HU (1) | HUP9901821A2 (ja) |
| IL (1) | IL124834A0 (ja) |
| WO (1) | WO1997025435A1 (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009219430A (ja) * | 2008-03-17 | 2009-10-01 | Tottori Univ | コラーゲンペプチドの製造方法 |
| WO2012035869A1 (ja) * | 2010-09-13 | 2012-03-22 | 株式会社龍泉堂 | 活性エピトープを有する非変性ii型コラーゲンの抽出方法 |
| WO2023167166A1 (ja) * | 2022-03-01 | 2023-09-07 | 学校法人近畿大学 | 肥料およびその製造方法 |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849336A (en) * | 1997-07-02 | 1998-12-15 | Abbott Laboratories | Method using sturgeon notochord for alleviating the symptoms of arthritis |
| US6025327A (en) * | 1997-08-08 | 2000-02-15 | Biocell Technology, Llc | Hydrolyzed collagen type II and use thereof |
| US20020115066A1 (en) * | 1998-11-26 | 2002-08-22 | Hope Ralph Graham | Viral therapeutics |
| WO2000052516A2 (en) | 1999-03-01 | 2000-09-08 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
| JP3731150B2 (ja) | 2000-08-22 | 2006-01-05 | 株式会社角弘 | 軟骨型プロテオグリカンの精製方法 |
| US6721142B1 (en) * | 2000-12-21 | 2004-04-13 | Western Digital (Fremont) Inc. | Non-corrosive GMR slider for proximity recording |
| US6773699B1 (en) | 2001-10-09 | 2004-08-10 | Tissue Adhesive Technologies, Inc. | Light energized tissue adhesive conformal patch |
| US6939364B1 (en) | 2001-10-09 | 2005-09-06 | Tissue Adhesive Technologies, Inc. | Composite tissue adhesive |
| US6780840B1 (en) | 2001-10-09 | 2004-08-24 | Tissue Adhesive Technologies, Inc. | Method for making a light energized tissue adhesive |
| US6780841B2 (en) | 2001-11-13 | 2004-08-24 | Biocell Technology, Llc | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same |
| US7628810B2 (en) | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
| US20050046794A1 (en) | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
| US7491350B2 (en) * | 2004-12-01 | 2009-02-17 | Acufocus, Inc. | Method of making an ocular implant |
| US7976577B2 (en) | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
| US9492272B2 (en) | 2009-08-13 | 2016-11-15 | Acufocus, Inc. | Masked intraocular implants and lenses |
| USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
| EP2502964A1 (de) | 2011-03-24 | 2012-09-26 | Molda AG | Verfahren zur Herstellung von Kollagen |
| EP2785296B1 (en) | 2011-12-02 | 2018-06-20 | AcuFocus, Inc. | Ocular mask having selective spectral transmission |
| CN103088096A (zh) * | 2012-12-30 | 2013-05-08 | 浙江中医药大学 | 一种以蕲蛇为原料提取ⅱ型胶原蛋白的方法 |
| US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
| US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
| CA3056759C (en) * | 2016-03-22 | 2024-01-23 | Avicenna Nutraceutical, Llc | Hydrolyzed collagen compositions and methods of making thereof |
| CA3099905A1 (en) | 2017-05-11 | 2018-11-15 | Avicenna Nutracetical, Llc | Methods for producing collagen |
| TWI817084B (zh) * | 2021-02-03 | 2023-10-01 | 惠合再生醫學生技股份有限公司 | 膠原蛋白的製備方法 |
| CN113563458B (zh) * | 2021-07-19 | 2023-07-21 | 嘉兴恒杰生物制药股份有限公司 | 一种非变性ii型胶原蛋白的制备方法 |
| US11980699B2 (en) | 2021-09-01 | 2024-05-14 | Shanghai Qisheng Biological Preparation Co., Ltd. | Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells |
| CN114106151A (zh) * | 2021-12-10 | 2022-03-01 | 中基惠诚科技有限公司 | 一种抗氧化活性胶原蛋白肽的制备方法 |
| WO2023125689A1 (en) | 2021-12-28 | 2023-07-06 | Shanghai Qisheng Biological Preparation Co., Ltd. | Hyaluronic acid-collagen copolymer compositions and medical applications thereof |
| CN118127110B (zh) * | 2024-04-10 | 2025-02-28 | 北京盛美诺生物技术有限公司 | 一种可缓解关节疼痛的非变性ii型胶原蛋白的制备方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB898105A (en) * | 1959-01-23 | 1962-06-06 | Olin Mathieson | Improvements in methods of and compositions for the treatment of bones |
| US3034852A (en) * | 1960-01-26 | 1962-05-15 | Japan Leather Mfg Co Ltd | Solubilization of insoluble collagen fibers and reconstitution thereof |
| US3121049A (en) * | 1960-09-19 | 1964-02-11 | Nihon Hikaku | Method for colloidally dispersing collagen |
| US3131130A (en) * | 1961-07-31 | 1964-04-28 | Ethicon Inc | Method of producing soluble collagen |
| US3314861A (en) * | 1963-05-11 | 1967-04-18 | Fujii Tadahiko | Method for solubilizing insoluble collagen fibers |
| US3530037A (en) * | 1967-03-20 | 1970-09-22 | Tomio Nishihara | Method for solubilization of collagen fibers with proteolytic enzymes |
| US3949073A (en) * | 1974-11-18 | 1976-04-06 | The Board Of Trustees Of Leland Stanford Junior University | Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution |
| CA1073360A (en) * | 1975-10-22 | 1980-03-11 | John R. Daniels | Non-antigenic collagen and articles of manufacture |
| US4164559A (en) * | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
| US4223984A (en) * | 1979-04-04 | 1980-09-23 | Opticol Corporation | Collagen soft contact lens |
| US4424208A (en) * | 1982-01-11 | 1984-01-03 | Collagen Corporation | Collagen implant material and method for augmenting soft tissue |
| JPS6212800A (ja) * | 1985-07-11 | 1987-01-21 | Eisai Co Ltd | 再構築ペプタイドおよび測定試薬 |
| US4713446A (en) * | 1985-09-06 | 1987-12-15 | Minnesota Mining And Manufacturing Company | Viscoelastic collagen solution for ophthalmic use and method of preparation |
| US4687518A (en) * | 1985-11-06 | 1987-08-18 | Optical Corp. | Method for manufacturing pyrogen-free collagen gels useful as contact lenses |
| US5399347A (en) * | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
| EP0359783B2 (en) * | 1987-06-24 | 2002-04-17 | Autoimmune, Inc. | Treatment of autoimmune diseases by oral administration of autoantigens |
| US5571499A (en) * | 1987-06-24 | 1996-11-05 | Autoimmune, Inc. | Treatment of autoimmune diseases by aerosol administration of autoantigens |
| US5571500A (en) * | 1987-06-24 | 1996-11-05 | Autoimmune, Inc. | Treatment of autoimmune diseases through administration by inhalation of autoantigens |
| US5106949A (en) * | 1989-09-15 | 1992-04-21 | Organogenesis, Inc. | Collagen compositions and methods for preparation thereof |
| US5138030A (en) * | 1989-10-10 | 1992-08-11 | Pachence James M | Process for extracting type I collagen form an avian source, and applications therefor |
| CA2070281C (en) * | 1989-12-20 | 2005-08-23 | David Allen Hafler | Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
| CA2077340A1 (en) * | 1990-03-02 | 1991-09-03 | Howard L. Weiner | Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens |
| CA2092905C (en) * | 1990-10-15 | 2002-01-08 | Howard L. Weiner | Treatment of autoimmune diseases by oral administration of autoantigens |
| US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
| US5374539A (en) * | 1991-06-17 | 1994-12-20 | Nimni; Marcel E. | Process for purifying collagen and generating bioprosthesis |
| BR9404597A (pt) * | 1994-03-15 | 1995-10-24 | Alemparte Gabriel Prat | Processo para obtenção de colágeno tipo II a partir de esterno de frango |
| US5856446A (en) * | 1995-07-07 | 1999-01-05 | Autoimmune Inc. | Method of treating rheumatoid arthritis with low dose type II collagen |
-
1997
- 1997-01-03 JP JP51533497A patent/JP3935938B2/ja not_active Expired - Fee Related
- 1997-01-03 WO PCT/US1997/000806 patent/WO1997025435A1/en not_active Ceased
- 1997-01-03 CA CA002238439A patent/CA2238439C/en not_active Expired - Fee Related
- 1997-01-03 AT AT97903850T patent/ATE423568T1/de not_active IP Right Cessation
- 1997-01-03 AU AU18319/97A patent/AU705719B2/en not_active Ceased
- 1997-01-03 HU HU9901821A patent/HUP9901821A2/hu unknown
- 1997-01-03 EP EP97903850A patent/EP0871763B1/en not_active Expired - Lifetime
- 1997-01-03 ES ES97903850T patent/ES2320939T3/es not_active Expired - Lifetime
- 1997-01-03 US US08/778,467 patent/US5840848A/en not_active Expired - Lifetime
- 1997-01-03 DE DE69739275T patent/DE69739275D1/de not_active Expired - Lifetime
- 1997-01-03 KR KR1019980704060A patent/KR19990071782A/ko not_active Withdrawn
- 1997-01-03 BR BR9706922A patent/BR9706922A/pt not_active Application Discontinuation
- 1997-01-03 IL IL12483497A patent/IL124834A0/xx not_active IP Right Cessation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009219430A (ja) * | 2008-03-17 | 2009-10-01 | Tottori Univ | コラーゲンペプチドの製造方法 |
| WO2012035869A1 (ja) * | 2010-09-13 | 2012-03-22 | 株式会社龍泉堂 | 活性エピトープを有する非変性ii型コラーゲンの抽出方法 |
| WO2023167166A1 (ja) * | 2022-03-01 | 2023-09-07 | 学校法人近畿大学 | 肥料およびその製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE423568T1 (de) | 2009-03-15 |
| HUP9901821A2 (hu) | 1999-09-28 |
| JP3935938B2 (ja) | 2007-06-27 |
| DE69739275D1 (de) | 2009-04-09 |
| CA2238439C (en) | 2004-11-30 |
| KR19990071782A (ko) | 1999-09-27 |
| ES2320939T3 (es) | 2009-05-29 |
| AU1831997A (en) | 1997-08-01 |
| BR9706922A (pt) | 1999-07-20 |
| AU705719B2 (en) | 1999-05-27 |
| CA2238439A1 (en) | 1997-07-17 |
| EP0871763A4 (en) | 2003-09-10 |
| WO1997025435A1 (en) | 1997-07-17 |
| EP0871763A1 (en) | 1998-10-21 |
| EP0871763B1 (en) | 2009-02-25 |
| US5840848A (en) | 1998-11-24 |
| IL124834A0 (en) | 1999-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3935938B2 (ja) | ▲ii▼型コラーゲンの調製法 | |
| WO1997025435A9 (en) | Method for preparation of type ii collagen | |
| EP1509546B1 (en) | Method for producing collagen | |
| JP2722014B2 (ja) | 無色素の魚の皮から天然コラーゲンを抽出する方法、無色素の魚の皮から得られる天然コラーゲン及び生体材料 | |
| CN102702346B (zh) | 一种从鱼皮中提取酸溶性胶原蛋白的方法及所得到的产品 | |
| JPH0331414B2 (ja) | ||
| US5270176A (en) | Method for the selective cleavage of fusion proteins with lysostaphin | |
| JPH03170571A (ja) | コラーゲン組成物及び該コラーゲン組成物の製造方法 | |
| JP2002520421A (ja) | プロテアーゼ感受性ii | |
| CN119119243B (zh) | 一种从鱼皮中提取鱼胶原蛋白的方法及其应用 | |
| JPS62502833A (ja) | ヒアルロン酸の製法 | |
| CN119530138B (zh) | 一种用于工业化细胞解离的多酶制剂及其使用方法和应用 | |
| US5811279A (en) | Method for activating prothrombin with polyethylene glycol | |
| US7741441B2 (en) | Method for producing type IV collagen | |
| CN118086439A (zh) | 一种获取高纯度去端肽的胶原蛋白的方法 | |
| JP3155746B1 (ja) | Ii型コラーゲンの製造方法 | |
| TWI236501B (en) | Process for extracting soluble collagen from animal tissue and products containing soluble collagen prepared therefrom | |
| JP2672587B2 (ja) | 新規ix型コラーゲン、それを構成する新規超高分子コンドロイチン硫酸及びそれらの製造法 | |
| JPH07241200A (ja) | ヒアルロン酸の製造法 | |
| CN117402234A (zh) | 一种去除胃蛋白酶残留的胶原蛋白提取工艺 | |
| CN119842848A (zh) | 水解胶原及其制备方法与应用 | |
| AU2005100078A4 (en) | Collagen and method for producing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040706 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040623 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040928 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060411 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060711 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060828 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061219 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061222 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070220 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070322 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100330 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110330 Year of fee payment: 4 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110330 Year of fee payment: 4 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120330 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130330 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130330 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140330 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |